New mode of action discovered for tamoxifen

IOWA CITY, Iowa -- First used to treat breast cancer more than 30 years ago, tamoxifen now is one of the most widely used breast cancer therapies. University of Iowa researchers have discovered a new mode of action for tamoxifen, which could lead to better targeting of the therapy and possibly the development of new anti-cancer drugs.

In breast tissue, tamoxifen acts as an anti-estrogen, meaning that it blocks the action of the hormone estrogen. Normal breast cells grow in response to estrogen in a controlled fashion. However, in breast cancer, this cell growth is out of control. Treatment with the anti-estrogen tamoxifen inhibits the uncontrolled cell growth and keeps cancer in check.

In a new study, which appears in the Jan. 15 issue of Clinical Cancer Research, researchers based at the Holden Comprehensive Cancer Center at the UI have identified another way that tamoxifen can prevent cancerous growth. The study indicates that tamoxifen treatment causes the re-expression of a tumor suppressor gene known as maspin.

Maspin protein has been shown to inhibit tumor invasion and metastasis, and in normal breast cells, maspin protein is abundant. However, in breast cancer, maspin gene expression is diminished or lost and tumors can form and spread unchecked. Previous studies have shown that reintroducing maspin into breast cancer cells, which have lost the gene expression, causes cancers to be less invasive.

The UI study showed that treatment with tamoxifen turned maspin expression back on in breast cancer cells that had lost the gene expression. The study suggests that one of tamoxifen's beneficial effects is due to its ability to turn maspin expression back on. Moreover, the researchers also found similar results in tissue samples from breast cancer patients who had been treated with tamoxifen.

"Looking at the tumor samples we found up-regulation of maspin in these samples too. That was further confirmation of what we s

Contact: Jennifer Brown
University of Iowa

Page: 1 2

Related biology news :

1. DNA lends scientists a hand, revealing new chemical reactions
2. Charting the future in prostate cancer care: A call to action
3. Defensive action by influenza viruses demonstrated by Hebrew university researcher
4. Long-term effects of carbon monoxide poisoning are an autoimmune reaction
5. Common call for action on European Research Council (ERC)
6. New technique helps scientists reveal interactions between genes and drugs
7. Rutgers cancer prevention expert calls for FDA action to reduce colon cancer and osteoporosis
8. Rutgers chemist uses NMR to elucidate protein-DNA interaction
9. Findings suggest need for new view of p53 cancer proteins interaction with DNA
10. A pregnant pause for unexpected interactions
11. Infusion of two peptides acts to accelerate appetite satisfaction

Post Your Comments:

(Date:5/25/2020)... ... , ... Oxford Nanopore Technologies is in advanced development of a new generation ... , The LamPORE assay is designed to be rapid, low cost, and ... of samples. Hardware and reagents sit outside current, squeezed supply chains for other ...
(Date:5/21/2020)... CARY, N.C. (PRWEB) , ... ... ... Solutions , the leading software-as-a-service (SaaS) provider of operations management solutions, today ... new BioMed module provides a cloud-based platform for connecting the people and ...
(Date:5/21/2020)... ... May 20, 2020 , ... Law Enforcement has always been a highly stressful ... The positions of these men and women put them constantly in harm’s way both ... precisely. Officers have always had to face very high daily stress. Now, COVID-19 introduces ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 29, 2020 , ... The Interlocal ... contracts to its membership, recently named BioFit Engineered Products an Awarded ... to purchase ergonomic seating, cafeteria tables, book trucks and carts at discounted pricing ...
(Date:6/28/2020)... ... 2020 , ... The Indoor Lab, a leading provider of sensor solutions for ... types to ensure cleanliness, distancing and occupancy with its patent pending WipeAway™ technology using ... will provide a health performance index system that scores all aspects of compliance similar ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for treating cancer, today announced the company has entered a license agreement with ... agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a ...
(Date:6/23/2020)... ... , ... Kerafast Inc. , developers of an online ... of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by ... entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment. , ...
Breaking Biology Technology:
Cached News: